News
New prescriptions for Wegovy among teenagers increased by 50% between 2023 and 2024, according to a June 3 report from healthcare data company Truveta. To analyze GLP-1 utilization trends among ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use ...
ReShape Lifesciences gains MDR and UKCA certification for all EU and UK devices, meeting strict regulatory standards well ...
Rising teen obesity prompts a surge in Novo Nordisk's Wegovy usage among adolescents, with prescriptions climbing 50% in 2024 ...
Regeneron's trevogrumab trial has proved, overall, successful - potentially providing a solution to a reported Wegovy side ...
Hims agreed to buy private European telehealth firm Zava, which operates in the U.K., Germany, France, and Ireland.
News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, ...
Stocks are struggling at the start of trade as lingering trade worries stick to this market, though investors managed to shake that off on Monday. That setup could work again for Tuesday. The S&P 500 ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
New data indicates that American teenagers are increasingly using the weight-loss drug Wegovy, as confidence in its use for ...
Telehealth platform Hims & Hers said on Tuesday it will acquire London-based startup Zava for an undisclosed amount, allowing it to launch its offerings in Germany, France and Ireland and reach more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results